Cargando…
Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy
BACKGROUND: Prostate-specific membrane antigen (PSMA) is a promising target for diagnostics and therapy of prostate carcinoma (PCa). Based on the hypothesis that PSMA expression can be modulated by variations in androgen deprivation therapy (ADT), we investigated the binding of a PSMA-directed radio...
Autores principales: | Meller, B., Bremmer, F., Sahlmann, C. O., Hijazi, S., Bouter, C., Trojan, L., Meller, J., Thelen, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648835/ https://www.ncbi.nlm.nih.gov/pubmed/26576996 http://dx.doi.org/10.1186/s13550-015-0145-8 |
Ejemplares similares
-
Enhancing PSMA-uptake with androgen deprivation therapy – a new way to detect prostate cancer metastases?
por: Leitsmann, Conrad, et al.
Publicado: (2019) -
The Role of PSMA PET/CT in the Primary Diagnosis and Follow-Up of Prostate Cancer—A Practical Clinical Review
por: Lisney, Anna Rebecca, et al.
Publicado: (2022) -
Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells
por: LIU, TIANCHENG, et al.
Publicado: (2012) -
(99m)Tc-Besilesomab-SPECT/CT in Infectious Endocarditis: Upgrade of a Forgotten Method?
por: Bouter, Caroline, et al.
Publicado: (2019) -
Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer
por: Plichta, Kristin A., et al.
Publicado: (2021)